Sign Up for a Free Account
  • Updated 02.19.2020
  • Released 06.27.1994
  • Expires For CME 02.19.2023

Alzheimer disease



Alzheimer disease is the most common cause of dementia (known as major neurocognitive disorder in the Fifth Edition of the Diagnostic and Statistical Manual for Mental Disorders) among people over age 65 years. In this article, the author presents an overview of the disease including clinical manifestations, pathophysiology, etiology, and diagnostic workup. Also included is information on results from clinical trials of diet and exercise.

Key points

• Alzheimer disease is the most common cause of dementia.

• Memory loss is the dominant feature in most patients, often accompanied by anomia, visuospatial deficits, and executive dysfunctions.

• Current anti-dementia drugs often reduce symptomatic decline rather than improve cognition.

• Apathy, depression, and agitation are frequent noncognitive symptoms.

• The usefulness of antipsychotic drugs for treatment of agitation is modest and limited by increased mortality risks; SSRIs may offer a better safety and efficacy profile than antipsychotics for agitation without psychosis.

• The prevalence of Alzheimer disease is rapidly increasing and is projected to continue to rise through the 2050s. This increase reflects an aging population as well as higher rates of diagnosis among affected individuals.

Historical note and terminology

Although cognitive decline in advanced age has been recognized throughout history, the understanding that it represents the result of specific disease states is more recent. In 1907 the German neurologist and pathologist Alois Alzheimer reported the case of a 56-year-old woman with progressive cognitive decline and behavior change associated with distinctive neuropathological features of senile plaques and neurofibrillary tangles (Alzheimer 1907). Although the term “Alzheimer disease” is often used synonymously with “dementia,” current theoretical frameworks distinguish the pathology of Alzheimer disease from the symptomatic expression, accounting for constructs like “preclinical Alzheimer disease” and “mild cognitive impairment due to Alzheimer disease.” For clarity and brevity in this article, “Alzheimer dementia” will be used to denote “dementia due to Alzheimer disease.”

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660



ISSN: 2831-9125